肥胖改变扩张型心肌病能量表型
研究比较正常体重扩张型心肌病(DCMNW)、肥胖扩张型心肌病(DCMOB)与正常体重对照(CTLNW)的心肌能量学,用心脏磁共振与31P波谱评估。DCMNW静息ATP递送降低,DCMOB经肌酸激酶(CK)的ATP需求更高,提示能量利用效率下降;饮食减重后左室重构改善且ATP递送率下降。
要点
- 正常体重DCM患者静息ATP递送降低,与左室射血分数相关。
- 肥胖DCM患者CK通量更高,提示能量利用效率下降。
- 饮食减重可改善左室重构与收缩功能,并降低ATP递送率。
核心结论
- 正常体重DCM与静息ATP递送降低相关。
- 肥胖DCM中经CK的ATP需求更高,提示能量利用效率下降。
- 饮食减重与心肌收缩力改善及ATP递送率下降相关,提示代谢效率改善。
研究设计与样本
- 全部受试者接受心脏磁共振成像与31P波谱检查以评估功能与能量学。
主要发现
- DCMNW的肌酸激酶(CK)通量较CTLNW低55%(P = 0.004),与左室射血分数相关(r = 0.4,P = 0.015)。
- DCMOB与DCMNW左室射血分数相似(DCMOB 41 ± 7%,DCMNW 38 ± 6%,P = 0.14),但DCMOB的CK通量高两倍(P < 0.001)。
- DCMOB经CK的速率更高[中位kf 0.21(0.14) vs. 0.11(0.12) s-1,P = 0.002]。
- 负荷增加时CTLNW的CK通量增加97%(P < 0.001),DCMNW无变化,DCMOB下降超过50%(P < 0.001)。
- 减重后左室舒张末期容积减少8%(P < 0.001),左室射血分数变化(40 ± 9% vs. 45 ± 10%,P = 0.002),ATP递送率下降7%(P = 0.049)。
临床怎么用
- 对肥胖合并扩张型心肌病患者,应关注体重管理作为改善心肌能量代谢与重构的干预方向。
- 评估心肌能量学有助于区分肥胖相关心肌病与扩张型心肌病的不同病理生理途径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: We sought to determine if myocardial energetics could distinguish obesity cardiomyopathy as a distinct entity from dilated cardiomyopathy. METHODS AND RESULTS: Sixteen normal weight participants with dilated cardiomyopathy (DCMNW), and 27 with DCM and obesity (DCMOB), were compared to 26 normal weight controls (CTLNW). All underwent cardiac magnetic resonance imaging and 31P spectroscopy to assess function and energetics. Nineteen DCMOB underwent repeat assessment after a dietary weight loss intervention. Adenosine triphosphate (ATP) delivery through creatine kinase (CK flux) was 55% lower in DCMNW than in CTLNW (P = 0.004), correlating with left ventricular ejection fraction (LVEF, r = 0.4, P = 0.015). In contrast, despite similar LVEF (DCMOB 41 ± 7%, DCMNW 38 ± 6%, P = 0.14), CK flux was two-fold higher in DCMOB (P < 0.001), due to higher rate through CK [median kf 0.21 (0.14) vs. 0.11 (0.12) s-1, P = 0.002]. During increased workload, the CTLNW heart increased CK flux by 97% (P < 0.001). In contrast, CK flux was unchanged in DCMNW and fell in DCMOB (by >50%, P < 0.001). Intentional weight loss was associated with positive left ventricular remodelling, with reduced left ventricular end-diastolic volume (by 8%, P < 0.001) and a change in LVEF (40 ± 9% vs. 45 ± 10%, P = 0.002). This occurred alongside a fall in ATP delivery rate with weight loss (by 7%, P = 0.049). CONCLUSIONS: In normal weight, DCM is associated with reduced resting ATP delivery. In obese DCM, ATP demand through CK is greater, suggesting reduced efficiency of energy utilization. Dietary weight loss is associated with significant improvement in myocardial contractility, and a fall in ATP delivery, suggesting improved metabolic efficiency. This highlights distinct energetic pathways in obesity cardiomyopathy, which are both different from dilated cardiomyopathy, and may be reversible with weight loss.
引用
- Rayner JJ, Peterzan MA, Clarke WT, et al. Obesity modifies the energetic phenotype of dilated cardiomyopathy. Eur Heart J. 2021. PMID: 34542592. doi:10.1093/eurheartj/ehab663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。